Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

Alliance Pharma Withdraws Final Dividend Despite Strong 2019 Results

Tue, 07th Apr 2020 13:13

(Alliance News) - Alliance Pharma PLC said Tuesday it will not pay a final dividend for 2019 to save cash in the face of the Covid-19 pandemic, in spite of a strong performance for 2019.

For 2019, the pharmaceutical company said pretax profit rose by 36% to GBP31.1 million from GBP22.8 million the year before, mainly due to the non-repeating impairment of an anti-malarial asset in 2018, as well as revenue growth.

Revenue for the year grew by 16% to GBP144.3 million from GBP124.0 million, driven by stronger sales in its International Star brands, as well as the first full year revenue contribution from anti-dandruff shampoo Nizoral, acquired from US pharmaceutical giant Johnson & Johnson in June 2018.

Alliance Pharma's sales from outside of the UK continued to grow, with International sales as a whole rising by 32% to GBP54.2 million, on Nizoral and strong demand for Kelo-cote.

Mainland Europe revenue rose by 28% to GBP32.5 million, and sales in the US increased by 11% to GBP6.1 million.

However, sales in the UK & Ireland declined by 2% to GBP51.4 million on a weaker performance from the group's heritage pharmaceutical products.

Looking ahead, Alliance Pharma said it expects to see some impact on revenue from the ongoing Covid-19 pandemic, however its supply chain has held up well and the group has continued to hold good levels of inventory.

"2019 saw another year of strong sales and profit growth, led by our consumer brands, particularly our International Stars. Cash generation was also very strong, allowing us to significantly reduce our borrowings. We are pleased with the way the Nizoral transition is progressing and look forward to the increased control we will have over the brand as the various territories fully transition to Alliance," said Chief Executive Officer Peter Butterfield.

"Notwithstanding the current uncertainty created by the coronavirus, our underlying business remains resilient, with strong financials, good liquidity and covenant headroom, and we look forward to continuing our path of growth in the years ahead," Butterfield added.

Shares in Alliance Pharma were up 6.5% at 66.00 pence on Tuesday in London.

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
5 Feb 2024 14:09

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...

5 Feb 2024 09:07

Alliance Pharma names Camillo Pane as chair

(Sharecast News) - Consumer healthcare company Alliance Pharma has appointed Camillo Pane to the role of chairman to "lead the company through its nex...

31 Jan 2024 10:34

RBC Capital Markets nudges down Alliance Pharma price target

(Sharecast News) - RBC Capital Markets nudged its price target on Alliance Pharma down to 60p from 65p on Wednesday as it said it was rebasing its for...

31 Jan 2024 09:21

LONDON BROKER RATINGS: Jefferies raises Spirax-Sarco; cuts Victrex

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

29 Jan 2024 11:59

Alliance Pharma reports annual boost in revenue; eyes flat 2024 profit

(Alliance News) - Alliance Pharma PLC on Monday said second-half recovery drove its full-year "record" revenue but noted that it does not expect profi...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.